{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:55:20Z","timestamp":1788317720997,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["MHRAP"],"award-info":[{"award-number":["MHRAP"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12185-022-03454-1","type":"journal-article","created":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T08:02:42Z","timestamp":1664697762000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease"],"prefix":"10.1007","volume":"117","author":[{"given":"Orly","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankeet","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rosovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Karp Leaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoon","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"issue":"2","key":"3454_CR1","first-page":"166","volume":"4","author":"O Leiva","year":"2022","unstructured":"Leiva O, Hobbs G, Ravid K, Libby P. Cardiovascular disease in myeloproliferative neoplasms. JACC: CardioOncology. 2022;4(2):166\u201382.","journal-title":"JACC: CardioOncology"},{"issue":"1","key":"3454_CR2","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.","journal-title":"Eur Respir J"},{"issue":"4","key":"3454_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society Of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"3","key":"3454_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/ejh.13197","volume":"102","author":"M Brabrand","year":"2019","unstructured":"Brabrand M, Hansen KN, Laursen CB, Larsen TS, Vestergaard H, Abildgaard N. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms. Eur J Haematol. 2019;102(3):227\u201334.","journal-title":"Eur J Haematol"},{"issue":"12","key":"3454_CR5","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.echo.2019.07.010","volume":"32","author":"J Kim","year":"2019","unstructured":"Kim J, Krichevsky S, Xie L, Palumbo MC, Rodriguez-Diego S, Yum B, et al. Incremental utility of right ventricular dysfunction in patients with myeloproliferative neoplasm-associated pulmonary hypertension. J Am Soc Echocardiogr. 2019;32(12):1574\u201385.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"3454_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/ejh.13543","volume":"106","author":"A Ferrari","year":"2021","unstructured":"Ferrari A, Scandura J, Masciulli A, Krichevsky S, Gavazzi A, Barbui T. Prevalence and risk factors for pulmonary hypertension associated with chronic myeloproliferative neoplasms. Eur J Haematol. 2021;106(2):250\u20139.","journal-title":"Eur J Haematol"},{"key":"3454_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2021.04.006","volume":"335","author":"E Pfeuffer-Jovic","year":"2021","unstructured":"Pfeuffer-Jovic E, Weiner S, Wilkens H, Schmitt D, Frantz S, Held M. Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension. Int J Cardiol. 2021;335:105\u201310.","journal-title":"Int J Cardiol"},{"issue":"2","key":"3454_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","volume":"5","author":"D Montani","year":"2017","unstructured":"Montani D, Girerd B, Jais X, Levy M, Amar D, Savale L, et al. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study. Lancet Respir Med. 2017;5(2):125\u201334.","journal-title":"Lancet Respir Med"},{"key":"3454_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.amjcard.2020.12.023","volume":"143","author":"JM Stempel","year":"2021","unstructured":"Stempel JM, Gopalakrishnan A, Krishnamoorthy P, Lo KB, Mittal V, Moghbeli N, et al. Pulmonary arterial hypertension in hospitalized patients with polycythemia vera (from the National Inpatient Database). Am J Cardiol. 2021;143:154\u20137.","journal-title":"Am J Cardiol"},{"issue":"Supp_1","key":"3454_CR10","first-page":"A10079\u2013A","volume":"144","author":"O Leiva","year":"2021","unstructured":"Leiva O, Bhatt A, Jenkins A, Rosovsky R, Karp-Leaf R, Goodarzi K, et al. Abstract 10079: risk of cardiovascular and all-cause mortality in patients with myeloproliferative neoplasms following heart failure hospitalization. Circulation. 2021;144(Supp_1):A10079-A.","journal-title":"Circulation"},{"issue":"1","key":"3454_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/2045893217702064","volume":"7","author":"I Singh","year":"2017","unstructured":"Singh I, Mikita G, Green D, Risquez C, Sanders A. Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series. Pulm Circ. 2017;7(1):261\u20137.","journal-title":"Pulm Circ"},{"issue":"18","key":"3454_CR12","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.2169\/internalmedicine.8629-16","volume":"56","author":"T Tachibana","year":"2017","unstructured":"Tachibana T, Nakayama N, Matsumura A, Nakajima Y, Takahashi H, Miyazaki T, et al. Pulmonary hypertension associated with pulmonary veno-occlusive disease in patients with polycythemia vera. Intern Med. 2017;56(18):2487\u201392.","journal-title":"Intern Med"},{"issue":"3","key":"3454_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.leu.2404943","volume":"22","author":"A Cortelezzi","year":"2008","unstructured":"Cortelezzi A, Gritti G, Del Papa N, Pasquini MC, Calori R, Gianelli U, et al. Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. Leukemia. 2008;22(3):646\u20139.","journal-title":"Leukemia"},{"issue":"2","key":"3454_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canep.2015.01.014","volume":"39","author":"J Wu","year":"2015","unstructured":"Wu J, Zhang L, Vaze A, Lin S, Juhaeri J. Risk of Wernicke\u2019s encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm. Cancer Epidemiol. 2015;39(2):242\u20139.","journal-title":"Cancer Epidemiol"},{"issue":"24","key":"3454_CR15","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1200\/JCO.2005.09.021","volume":"23","author":"M Massa","year":"2005","unstructured":"Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G, et al. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(24):5688\u201395.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3454_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2353\/ajpath.2008.070705","volume":"172","author":"K Asosingh","year":"2008","unstructured":"Asosingh K, Aldred MA, Vasanji A, Drazba J, Sharp J, Farver C, et al. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol. 2008;172(3):615\u201327.","journal-title":"Am J Pathol"},{"issue":"13","key":"3454_CR17","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1182\/blood-2010-09-306357","volume":"117","author":"S Farha","year":"2011","unstructured":"Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011;117(13):3485\u201393.","journal-title":"Blood"},{"issue":"6","key":"3454_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7326\/0003-4819-143-6-200509200-00017","volume":"143","author":"U Popat","year":"2005","unstructured":"Popat U, Frost A, Liu E, May R, Bag R, Reddy V, et al. New onset of myelofibrosis in association with pulmonary arterial hypertension. Ann Intern Med. 2005;143(6):466\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3454_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-021-01064-8","volume":"14","author":"K Minakawa","year":"2021","unstructured":"Minakawa K, Yokokawa T, Ueda K, Nakajima O, Misaka T, Kimishima Y, et al. Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice. J Hematol Oncol. 2021;14(1):52.","journal-title":"J Hematol Oncol"},{"issue":"7648","key":"3454_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefrancais","year":"2017","unstructured":"Lefrancais E, Ortiz-Munoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544(7648):105\u20139.","journal-title":"Nature"},{"issue":"24","key":"3454_CR21","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.1182\/bloodadvances.2020002843","volume":"4","author":"AK Yeung","year":"2020","unstructured":"Yeung AK, Villacorta-Martin C, Hon S, Rock JR, Murphy GJ. Lung megakaryocytes display distinct transcriptional and phenotypic properties. Blood Adv. 2020;4(24):6204\u201317.","journal-title":"Blood Adv"},{"issue":"2","key":"3454_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.6","volume":"7","author":"O Leiva","year":"2017","unstructured":"Leiva O, Ng SK, Chitalia S, Balduini A, Matsuura S, Ravid K. The role of the extracellular matrix in primary myelofibrosis. Blood Cancer J. 2017;7(2): e525.","journal-title":"Blood Cancer J"},{"issue":"6","key":"3454_CR23","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1183\/09031936.00139009","volume":"34","author":"T Lung","year":"2009","unstructured":"Lung T, Galie N, Task Force for D, Treatment of Pulmonary Hypertension of European Society of C, European Respiratory S, International Society of H, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34(6):1219\u201363.","journal-title":"Eur Respir J"},{"issue":"4","key":"3454_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.gheart.2012.08.001","volume":"7","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Glob Heart. 2012;7(4):275\u201395.","journal-title":"Glob Heart"},{"issue":"2","key":"3454_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.leu.2404914","volume":"22","author":"G Barosi","year":"2008","unstructured":"Barosi G, Mesa RA, Thiele J, Cervantes F, Campbell PJ, Verstovsek S, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment. Leukemia. 2008;22(2):437\u20138.","journal-title":"Leukemia"},{"key":"3454_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4770","author":"Y Jian","year":"2022","unstructured":"Jian Y, Zhou H, Wang Y, Zhang Z, Yang G, Geng C, et al. Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients. Cancer Med. 2022. https:\/\/doi.org\/10.1002\/cam4.4770.","journal-title":"Cancer Med"},{"issue":"1","key":"3454_CR27","doi-asserted-by":"publisher","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","volume":"53","author":"A Frost","year":"2019","unstructured":"Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1):1801904.","journal-title":"Eur Respir J"},{"issue":"3","key":"3454_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-0609.2008.01192.x","volume":"82","author":"M Karimi","year":"2009","unstructured":"Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol. 2009;82(3):213\u20138.","journal-title":"Eur J Haematol"},{"issue":"1","key":"3454_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0609.2011.01620.x","volume":"87","author":"H Amoozgar","year":"2011","unstructured":"Amoozgar H, Farhani N, Khodadadi N, Karimi M, Cheriki S. Comparative study of pulmonary circulation and myocardial function in patients with beta-thalassemia intermedia with and without hydroxyurea, a case-control study. Eur J Haematol. 2011;87(1):61\u20137.","journal-title":"Eur J Haematol"},{"issue":"8","key":"3454_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ajh.21446","volume":"84","author":"M Olnes","year":"2009","unstructured":"Olnes M, Chi A, Haney C, May R, Minniti C, Jt T, et al. Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea. Am J Hematol. 2009;84(8):530\u20132.","journal-title":"Am J Hematol"},{"issue":"2","key":"3454_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ajh.20509","volume":"81","author":"E Rumi","year":"2006","unstructured":"Rumi E, Passamonti F, Boveri E, De Amici M, Astori C, Braschi M, et al. Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia. Am J Hematol. 2006;81(2):124\u20137.","journal-title":"Am J Hematol"},{"issue":"11","key":"3454_CR32","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00277-021-04636-3","volume":"100","author":"F Chenou","year":"2021","unstructured":"Chenou F, Hounkpe BW, Domingos IF, Tonasse WV, Batista THC, Santana RM, et al. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients. Ann Hematol. 2021;100(11):2669\u201376.","journal-title":"Ann Hematol"},{"key":"3454_CR33","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3389\/fimmu.2020.01488","volume":"11","author":"SS Santana","year":"2020","unstructured":"Santana SS, Pitanga TN, de Santana JM, Zanette DL, Vieira JJ, Yahouedehou S, et al. Hydroxyurea scavenges free radicals and induces the expression of antioxidant genes in human cell cultures treated with hemin. Front Immunol. 2020;11:1488.","journal-title":"Front Immunol"},{"issue":"7","key":"3454_CR34","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/leu.2014.5","volume":"28","author":"A Tabarroki","year":"2014","unstructured":"Tabarroki A, Lindner DJ, Visconte V, Zhang L, Rogers HJ, Parker Y, et al. Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis. Leukemia. 2014;28(7):1486\u201393.","journal-title":"Leukemia"},{"issue":"6","key":"3454_CR35","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.3324\/haematol.2014.120816","volume":"100","author":"AT Low","year":"2015","unstructured":"Low AT, Howard L, Harrison C, Tulloh RM. Pulmonary arterial hypertension exacerbated by ruxolitinib. Haematologica. 2015;100(6):e244\u20135.","journal-title":"Haematologica"},{"issue":"2","key":"3454_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCIMAGING.113.001184","volume":"7","author":"WL Miller","year":"2014","unstructured":"Miller WL, Mahoney DW, Enriquez-Sarano M. Quantitative doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: independent effect of pulmonary hypertension. Circ Cardiovasc Imaging. 2014;7(2):330\u20136.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"3454_CR37","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.mayocp.2021.03.037","volume":"96","author":"N Patel","year":"2021","unstructured":"Patel N, Narasimhan B, Bandyopadhyay D, Amreia M, Chakraborty S, Hajra A, et al. Impact of pulmonary hypertension on in-hospital outcomes and 30-day readmissions following percutaneous coronary interventions. Mayo Clin Proc. 2021;96(8):2058\u201366.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3454_CR38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1182\/blood-2012-03-419275","volume":"120","author":"K Asosingh","year":"2012","unstructured":"Asosingh K, Farha S, Lichtin A, Graham B, George D, Aldred M, et al. Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. Blood. 2012;120(6):1218\u201327.","journal-title":"Blood"},{"issue":"3","key":"3454_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.healun.2014.09.009","volume":"34","author":"EC Roach","year":"2015","unstructured":"Roach EC, Park MM, Tang WH, Thomas JD, Asosingh K, Kalaycio M, et al. Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms. J Heart Lung Transplant. 2015;34(3):390\u20134.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"3454_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165\u201375.","journal-title":"Circ Res"},{"issue":"1","key":"3454_CR41","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1038\/s41467-021-26435-0","volume":"12","author":"Y Kimishima","year":"2021","unstructured":"Kimishima Y, Misaka T, Yokokawa T, Wada K, Ueda K, Sugimoto K, et al. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils. Nat Commun. 2021;12(1):6177.","journal-title":"Nat Commun"},{"issue":"6","key":"3454_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","volume":"4","author":"S Sano","year":"2019","unstructured":"Sano S, Wang Y, Yura Y, Sano M, Oshima K, Yang Y, et al. JAK2 (V617F) -mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure. JACC Basic Transl Sci. 2019;4(6):684\u201397.","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"3454_CR43","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/10428194.2020.1864351","volume":"62","author":"NA Khan","year":"2021","unstructured":"Khan NA, Ahuja KA, Wang X, Chaisson NF. Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension. Leuk Lymphoma. 2021;62(6):1458\u201365.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3454_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1751-7133.2010.00202.x","volume":"17","author":"HW Farber","year":"2011","unstructured":"Farber HW, Foreman AJ, Miller DP, McGoon MD. REVEAL registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension. Congest Heart Fail. 2011;17(2):56\u201364.","journal-title":"Congest Heart Fail"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03454-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:21:24Z","timestamp":1672849284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03454-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03454-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant disclosures or conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Massachusetts General Hospital Institutional Review Board. Research was carried out in accordance with the Declaration of Helsinki. The requirement of informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"It is not applicable given no personal identifiable patient information included in publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}